Home
>>
Products
>>
Antibodies
>>
Recombinant Antibodies
>
Anti-Human CD3E & EpCAM Recombinant Antibody(Catumaxomab)

Anti-Human CD3E & EpCAM Recombinant Antibody(Catumaxomab)

Product Number

YR1139

Alias

科研级 Catumaxomab ( 卡妥索单抗 ), Anti-CD3E & EpCAM Recombinant Antibody, Research Grade Catumaxomab

Specifications
  • 1mg
  • 5mg
Product Description
Alias科研级 Catumaxomab ( 卡妥索单抗 ), Anti-CD3E & EpCAM Recombinant Antibody, Research Grade Catumaxomab
Catalog NumberYR1139
Molecular NameCatumaxomab
Size1mg, 5mg
ClonityMonoclonal
Purity>95% as determined by SDS-PAGE
Concentration1mg/ml
Antibody IsotypeIgG2a Kappa/G2b Lambda
FormulationPBS, pH7.5
BackgroundCatumaxomab (trade name Removab) is a rat-mouse hybrid monoclonal antibody which is used to treat malignant ascites, a condition occurring in people with metastasizing cancer. It binds to antigens CD3 and EpCAM. It was developed by Fresenius Biotech and Trion Pharma (Germany).
CAS Number509077-98-9
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
RemarksThis product is for research use only.
Shipping ConditionShipped on ice packs.
Molecular Weight150.51 kDa
TargetCD3E & EpCAM[Homo sapiens]

Login

Don’t have an account?Sign Up Now

Register

Already have an account?Log In Now

Inquire Now